Published in Br J Cancer on July 19, 2004
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res (2014) 10.77
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol Med (2010) 6.38
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest (2009) 5.07
COSMIC 2005. Br J Cancer (2006) 5.07
Functional copy-number alterations in cancer. PLoS One (2008) 4.27
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncol (2012) 4.19
Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol (2010) 3.77
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood (2007) 3.73
CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature (2011) 3.72
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol (2011) 3.55
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2011) 3.40
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. Blood (2008) 3.30
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res (2010) 3.21
U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet (2010) 2.99
miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet (2012) 2.89
Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron (2012) 2.84
The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer (2012) 2.79
Somatic mutation, genomic variation, and neurological disease. Science (2013) 2.72
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med (2013) 2.66
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet (2013) 2.53
Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science (2014) 2.42
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet (2011) 2.36
Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell (2011) 2.24
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res (2011) 2.24
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Res Treat (2011) 2.23
A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell (2009) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
Visualizing multidimensional cancer genomics data. Genome Med (2013) 2.19
A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst (2015) 2.13
Predicting the functional consequences of cancer-associated amino acid substitutions. Bioinformatics (2013) 2.12
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest (2012) 2.01
EnrichNet: network-based gene set enrichment analysis. Bioinformatics (2012) 1.92
Putative cis-regulatory drivers in colorectal cancer. Nature (2014) 1.92
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin Cancer Res (2012) 1.92
Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist Updat (2008) 1.90
Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol (2010) 1.87
MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res (2007) 1.81
A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci U S A (2010) 1.81
The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell (2013) 1.75
Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2. J Cell Biol (2010) 1.73
The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep (2014) 1.72
FancyGene: dynamic visualization of gene structures and protein domain architectures on genomic loci. Bioinformatics (2009) 1.67
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov (2012) 1.59
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients. Br J Cancer (2008) 1.55
Penile cancer: current therapy and future directions. Ann Oncol (2013) 1.54
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A (2013) 1.54
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature (2013) 1.52
Epidermal growth factor receptor mutations in lung adenocarcinoma. Lab Invest (2013) 1.49
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Res (2010) 1.48
Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing. PLoS One (2016) 1.43
Molecular prescreening to select patient population in early clinical trials. Nat Rev Clin Oncol (2012) 1.40
ChimerDB 2.0--a knowledgebase for fusion genes updated. Nucleic Acids Res (2009) 1.36
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci Signal (2009) 1.35
A bioinformatics workflow for variant peptide detection in shotgun proteomics. Mol Cell Proteomics (2011) 1.34
Clinical relevance of KRAS in human cancers. J Biomed Biotechnol (2010) 1.34
Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet (2014) 1.33
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer (2009) 1.32
A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res (2013) 1.30
Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res (2012) 1.29
Dnmt3a and Dnmt3b have overlapping and distinct functions in hematopoietic stem cells. Cell Stem Cell (2014) 1.28
EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature (2015) 1.28
Extraction of human kinase mutations from literature, databases and genotyping studies. BMC Bioinformatics (2009) 1.28
High throughput interrogation of somatic mutations in high grade serous cancer of the ovary. PLoS One (2011) 1.28
From bytes to bedside: data integration and computational biology for translational cancer research. PLoS Comput Biol (2007) 1.27
Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers? Anticancer Agents Med Chem (2012) 1.26
Systematic analysis of genotype-specific drug responses in cancer. Int J Cancer (2012) 1.23
Collections of simultaneously altered genes as biomarkers of cancer cell drug response. Cancer Res (2013) 1.23
Deregulation of H3K27 methylation in cancer. Nat Genet (2010) 1.23
Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers. Proc Natl Acad Sci U S A (2012) 1.22
Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. J Transl Med (2011) 1.21
ChimerDB--a knowledgebase for fusion sequences. Nucleic Acids Res (2006) 1.20
Bi-directional SIFT predicts a subset of activating mutations. PLoS One (2009) 1.19
Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum Mol Genet (2012) 1.19
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc Natl Acad Sci U S A (2012) 1.17
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells. Clin Cancer Res (2011) 1.17
Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells. Hum Gene Ther (2008) 1.17
Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem (2015) 1.16
Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study. PLoS One (2014) 1.15
The structural mechanism of KCNH-channel regulation by the eag domain. Nature (2013) 1.15
CanProVar: a human cancer proteome variation database. Hum Mutat (2010) 1.15
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med (2010) 1.14
Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling. J Biol Chem (2010) 1.14
Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res (2014) 1.14
Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS One (2009) 1.14
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res (2010) 1.14
Fast and scalable inference of multi-sample cancer lineages. Genome Biol (2015) 1.13
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery. BMC Evol Biol (2011) 1.12
Structural polymorphism within a regulatory element of the human KRAS promoter: formation of G4-DNA recognized by nuclear proteins. Nucleic Acids Res (2008) 1.12
PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system. Clin Cancer Res (2013) 1.11
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet (2016) 1.10
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood (2014) 1.08
Natural selection of protein structural and functional properties: a single nucleotide polymorphism perspective. Genome Biol (2008) 1.08
A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput Biol (2012) 1.07
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
The Bioperl toolkit: Perl modules for the life sciences. Genome Res (2002) 58.63
The Pfam protein families database. Nucleic Acids Res (2004) 56.46
A census of human cancer genes. Nat Rev Cancer (2004) 36.20
The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res (2003) 24.72
Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat (2003) 12.88
The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat (2002) 12.39
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature (1982) 11.92
Ensembl 2004. Nucleic Acids Res (2004) 11.88
Database resources of the National Center for Biotechnology Information: update. Nucleic Acids Res (2004) 9.85
HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res (2002) 4.08
Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (1983) 3.86
Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26
The UMD-p53 database: new mutations and analysis tools. Hum Mutat (2003) 2.89
The Ensembl genome database project. Nucleic Acids Res (2002) 40.87
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet (2008) 16.09
Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26
Ensembl 2004. Nucleic Acids Res (2004) 11.88
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst (1999) 6.48
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
COSMIC 2005. Br J Cancer (2006) 5.07
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (1994) 4.78
A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci U S A (1996) 4.30
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet (1996) 3.56
Positive control and autogenous regulation of the nifLA promoter in Klebsiella pneumoniae. Nature (1983) 3.43
Reproductive effects of four phthalic acid esters in the mouse. Toxicol Appl Pharmacol (1987) 3.21
Cancer and genomics. Nature (2001) 3.15
BioMart Central Portal: an open database network for the biological community. Database (Oxford) (2011) 3.03
An SNP map of human chromosome 22. Nature (2000) 2.99
Production of soluble MHC class II proteins with covalently bound single peptides. Nature (1994) 2.98
Breast cancer genetics: what we know and what we need. Nat Med (2001) 2.96
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene (1995) 2.91
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene (2007) 2.83
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet (1997) 2.77
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A (2000) 2.70
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 2.38
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst (1998) 2.33
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A (1998) 2.22
The genetics of breast cancer susceptibility. Annu Rev Genet (1998) 2.21
The MHC haplotype project: a resource for HLA-linked association studies. Tissue Antigens (2002) 2.16
Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. Nature (1989) 2.05
The extent of linkage disequilibrium in four populations with distinct demographic histories. Am J Hum Genet (2000) 2.03
Recommendations for spacing of test chemical concentrations in the mouse lymphoma tk mutation assay (MLA) Mutat Res (1998) 2.01
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet (2001) 1.97
Novel, rapid optical immunoassay technique for detection of group A streptococci from pharyngeal specimens: comparison with standard culture methods. J Clin Microbiol (1993) 1.97
A polymorphic stop codon in BRCA2. Nat Genet (1996) 1.95
Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour. J Med Genet (2005) 1.94
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet (1998) 1.88
Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke (2000) 1.86
Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg (1996) 1.83
Misidentified cell. Nature (1989) 1.81
AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes. Bioinformatics (2007) 1.80
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet (1996) 1.79
Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem (1995) 1.78
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol (1990) 1.76
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia (2008) 1.75
Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res (1998) 1.73
HIV infection and lymphoma. J Clin Pathol (2007) 1.67
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun (2000) 1.63
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
AIDS vaccine development. Science (1998) 1.62
The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet (1997) 1.62
Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol (1995) 1.61
Spine radiographs in patients with low-back pain. An epidemiological study in men. J Bone Joint Surg Am (1984) 1.60
Linkage map integration. Genomics (1996) 1.54
A multicenter analysis of percutaneous discectomy. Spine (Phila Pa 1976) (1990) 1.53
Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer (2000) 1.52
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia (2008) 1.51
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia (2007) 1.51
Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol (1999) 1.50
Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke (1998) 1.50
The gene for Darier's disease maps to chromosome 12q23-q24.1. Hum Mol Genet (1993) 1.47
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res (1998) 1.46
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ (1996) 1.45
Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence. Proc Natl Acad Sci U S A (1985) 1.45